CHICAGO, IL - September 01, 2026 - Aagami, Inc. is pleased to announce a strategic new client win: we have been appointed by a venture-backed bio...
Published : 01 Sep 2026
Read MoreCHICAGO, IL — August 01, 2026 — Aagami, Inc., a premier life sciences management consulting firm based in the Chicago area, announced today t...
Published : 01 Aug 2026
Read MoreCHICAGO, IL - July 07, 2026: Aagami is pleased to announce a new client win: we have been appointed by an innovative biopharmaceutical company ba...
Published : 07 Jul 2026
Read MoreCHICAGO, IL — July 2, 2026 — Aagami, Inc., a premier global life sciences consulting firm, today announced it has been appointed by an innova...
Published : 02 Jul 2026
Read MoreCHICAGO, IL — July 1, 2026 — Aagami, Inc., a premier global life sciences consulting firm, is proud to announce a new client win. An innovati...
Published : 01 Jul 2026
Read MoreCHICAGO, IL — June 19, 2026 — Marking its second major East Asian partnering mandate in the medical technology sector this week, Aagami, Inc....
Published : 19 Jun 2026
Read MoreCHICAGO, IL — June 18, 2026 — Aagami, Inc. has received a new strategic assignment from a highly valued existing client. Under this expanded ...
Published : 18 Jun 2026
Read MoreAagami is proud to announce a New Client Win. We have been officially appointed by a prominent, rapidly growing global pharmaceutical company to ...
Published : 16 Jun 2026
Read MoreAagami has been awarded a new mandate by its French biotech client to support the out-licensing of NFL-101, the client’s lead Phase 3 asset for smok...
Published : 01 Jun 2026
Read MoreAagami, Inc., a boutique global life science strategic consulting firm, has been awarded an exclusive, unrestricted global advisory assignment by a pr...
Published : 01 Jun 2026
Read More